Warning issued by FDA over "Liqiang 4 Capsules"

The FDA has recently issued a warning regarding the consumption of Liqiang 4 Dietary Supplement Capsules because they contain glyburide - a drug that could have serious, life-threatening consequences in some people. The warning from the FDA has come after they learned of the potential problem through an anonymous consumer complaint which was followed up with testing that revealed the presence of glyburide in the product.

Glyburide is a drug used to lower blood sugar, and is safe and effective when used as labeled in FDA-approved medications. People who have low blood sugar or those with diabetes can receive dangerously high amounts of glyburide by consuming Liqiang 4. Consumers are asked to immediately stop using these products , dispose of it immediately and seek medical attention, if they have symptoms of fatigue, excessive hunger, profuse sweating, or numbness of the extremities.

The FDA is presently evaluating Liquang 1 and other versions of this line of products to determine their composition and safety. The product is manufactured by Liqiang Research Institute, China, and marketed throughout the United States in herbal stores . The product is sold as part of a shrink-wrapped two bottle set. One of the 90 capsule bottles is labeled Liqiang 4 Dietary Supplement Capsules, the other bottle is promoted as a "bonus pack" of Liqiang 1.The product has also been termed "Liqiang Xiao Ke Ling" (Liqiang Thirst Quenching Efficacious) in ads in Chinese language publications which also promote it as useful for the control of diabetes and being derived from only natural ingredients.

All consumers, healthcare providers and care givers are urged by the FDA to report any adverse events related to this product to MedWatch, the FDA's voluntary reporting program or online at www.fda.gov/medwatch/report.htm.